These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6362257)

  • 41. [Fluocortin butyl in various dermatoses in childhood].
    Nemelka O; Occella C; Schiazza L; Persi A; Rampini E
    G Ital Dermatol Venereol; 1983; 118(1):VII-X. PubMed ID: 6358002
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of chronic eczemas. The comparative efficacy of two creams.
    Doherty JC; MacRae KD; Platt NE
    Practitioner; 1979 Apr; 222(1330):561-3. PubMed ID: 382173
    [No Abstract]   [Full Text] [Related]  

  • 43. The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream.
    Kircik LH; Del Rosso JQ
    J Drugs Dermatol; 2012 Oct; 11(10):1194-8. PubMed ID: 23134984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical trial of diflucortolone. Preliminary report].
    Hernańdez-Peŕez E
    Med Cutan Ibero Lat Am; 1981; 9(3):229-32. PubMed ID: 7026942
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative study of bufexamac (Droxaryl) ointment and of its excipient on psoriasis cases: double-blind test.
    Van der Meersch J
    Curr Ther Res Clin Exp; 1974 Sep; 16(9):904-8. PubMed ID: 4214665
    [No Abstract]   [Full Text] [Related]  

  • 46. [Are topical corticoids advantageous and justifiable in the treatment of dermatomycoses? (Travocort cream and Travogen cream were compared in 100 patients in an interindividual double-blind trial) (author's transl)].
    Nolting S; Langen ML
    Mykosen; 1980 Dec; 23(12):699-706. PubMed ID: 7012612
    [No Abstract]   [Full Text] [Related]  

  • 47. Grass pollen-induced hay fever treated with a new steroid fluocortin butylester (FCB).
    Moesgaard Nielsen V; Vinther B; Illum P
    Rhinology; 1983 Sep; 21(3):257-63. PubMed ID: 6356306
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatments of different dermatoses with diflucortolonvalerat 0,1% (nerisona). Report on multicentric tests in Switzerland (author's transl)].
    Straehl B
    Schweiz Rundsch Med Prax; 1978 Aug; 67(35):1277-84. PubMed ID: 693460
    [No Abstract]   [Full Text] [Related]  

  • 49. Use of bufexamac suppositories in rectal conditions.
    Samsi AB
    J Postgrad Med; 1975 Jul; 21(3):131-4. PubMed ID: 1206602
    [No Abstract]   [Full Text] [Related]  

  • 50. Therapeutic efficacy of bufexamac in rheumatoid arthritis: a double-blind comparison with indomethacin.
    Pavelka K; Wagenhauser F
    Curr Ther Res Clin Exp; 1970 Feb; 12(2):69-72. PubMed ID: 4984321
    [No Abstract]   [Full Text] [Related]  

  • 51. [Difluocortolone valerate in various dermatosis].
    Arellano FO
    Alergia; 1976 Jul; 23(3):129-37. PubMed ID: 962031
    [No Abstract]   [Full Text] [Related]  

  • 52. Double-blind study of prednicarbate versus fluocortin butyl ester in atopic dermatitis.
    Aliaga A; Rodríguez M; Armijo M; Bravo J; Avila AL; Mascaro JM; Ferrando J; Del Rio R; Lozano R; Balaguer A
    Int J Dermatol; 1996 Feb; 35(2):131-2. PubMed ID: 8850046
    [No Abstract]   [Full Text] [Related]  

  • 53. Allergy to bufexamac.
    Van Hecke E
    Arch Belg Dermatol; 1973; 29(4):301-3. PubMed ID: 4802391
    [No Abstract]   [Full Text] [Related]  

  • 54. [Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part I: Comparative study of diflucortolone valerate with fluocortolone, -capronate, -pivalate in a double-blind contralateral design with topical application (author's transl)].
    Reckers VR; Wendt H
    Arzneimittelforschung; 1976; 26(7b):1499-504. PubMed ID: 795433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of bufexamac for rheumatoid arthritis.
    Rose BS; Isdale IC; Conlon PW
    Curr Ther Res Clin Exp; 1970 Mar; 12(3):150-3. PubMed ID: 4985493
    [No Abstract]   [Full Text] [Related]  

  • 56. Contact dermatitis due to bufexamac.
    Melino M; Bardazzi F; Manuzzi P
    Contact Dermatitis; 1987 May; 16(5):287. PubMed ID: 2957160
    [No Abstract]   [Full Text] [Related]  

  • 57. [The use of difluocortolone valerate for various dermatoses].
    Saraceno EF; Viglioglia A
    Z Hautkr; 1976; 51 Suppl 1():60-1. PubMed ID: 795178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of inflammatory dermatoses with difluocortolone valerate].
    Filho JL; Lacet IG; Calheiros de Lima ME; Santos Oliveira VL
    Z Hautkr; 1976; 51 Suppl 1():40-2. PubMed ID: 795187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clocortolone pivalate: a topical corticosteroid with a unique structure.
    Kircik LH
    J Drugs Dermatol; 2013 Feb; 12(2):s3-4. PubMed ID: 23377404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Therapeutic effect and effect on the pituitary adrenal functions of fluocortine-butylester in eczema during childhood (author's transl)].
    Favrod-Coune E; Sizonenko PC; Paunier L; Varonier H; Hunziker N
    Dermatologica; 1978; 157(5):297-9. PubMed ID: 150351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.